Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2

• Status: Unknown status
• Trial end date: 2021-08-01
• Target enrollment: 0
• Participant gender: All

Summary

In the stage of randomized controlled study, our purpose is to obtain the Intraoperative anticoagulation program supported by evidence-based medicine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Tiantan Hospital
• Collaborators: First Affiliated Hospital of Fujian Medical University; Fujian Medical University Union Hospital; Kunming Medical University; Nanjing PLA General Hospital; Tang-Du Hospital
• Treatments: Calcium heparin; Heparin

Criteria

Inclusion Criteria:

1.All patients undergoing hybird surgery.

Exclusion Criteria:

1. Poor general condition , severe primary disease, surgical contraindications

2. Patient or family refused surgery

3. Fusiform aneurysm,Traumatic aneurysm,Infectious aneurysms

4. Combined with other hemorrhagic cerebrovascular disease

5. Combined with malignant brain tumor

6. Perinatal, Pregnancy

7. Patients unwilling to participate in the trial